Navigating the area of end-of-life care and access to medications like this drug in New South Wales, NSW, requires a careful grasp of the detailed legal structure. Currently, this powerful sedative does not have a official place on the Pharmaceutical Benefits Scheme (this program) and is therefore not regularly prescribed by clinical professionals.